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i. ABSTRACT 
An adequate multiplication rate in vivo is crucial for an infectious agent to cause clinical 
disease and achieve its transmission to new hosts. Despite their key importance, the 
nutritional and metabolic determinants of pathogen proliferation within the host remain a 
neglected area of research in infection biology. In this MSc thesis I have investigated the 
carbon metabolites used by the bacterial intracellular pathogen Listeria monocytogenes to 
grow within host cells. 
Previous work in the Vazquez -Boland laboratory demonstrated that, via a specific permease 
named Hpt, L. monocytogenes steals hexose phosphates from the host cell to fuel its rapid 
intracellular growth. Albeit more slowly, mutants lacking this permease are still able to 
replicate intracellularly, indicating that Listeria uses other carbon substrates from the host 
cell. Evidence suggested that free glucose could be this additional carbon substrate. To test 
this hypothesis, I sought to obtain a glucose utilisation- deficient mutant by disabling the main 
transport systems involved in glucose uptake by L. monocytogenes. A double mutant was 
constructed which lacked the central component of the phosphoenolpyruvate:sugar 
phosphotransferase system (PTS) Hpr (PtsH) necessary for PTS- dependent sugar transport, 
plus the main non -PTS specific glucose transporter GIcU1. The double ptsH /glucU1 knock- 
out mutant was virtually unable to grow on glucose in vitro and to proliferate within HeLa 
epithelial cells in conditions in which free glucose is in excess, indicating that glucose is a 
main intracellular carbon source for L. monocytogenes. 
I also sought to provide evidence for this conclusion from the host cell side. Using siRNA 
knockdown assays, HeLa cells were depleted of hexokinase, the enzyme that converts all 
the incoming free glucose into glucose -6- phosphate. A Ahpt mutant unable to use hexose 
phosphates showed wild -type growth in the hexokinase -depleted host cells, further indicating 
that free glucose, before conversion into glucose -6- phosphate and entering glycolysis, is a 
major carbon substrate for intracellular Listeria. 
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The genus Listeria contains eight species, of which only L. 
monocytogenes and L. ivanovii are able to cause disease, the rest of them 
(L. seeligeri, L. innocua, L. welshimeri, L. grayi, L. marthii and L. 
weihenstephanensis) are not pathogenic (Graves et al., 2010; Halter et al., 
2013). From the pathogenic species of Listeria, L.monocytogenes is the most 
important infection agent in humans being also able to infect animals. Only a 
few human infection cases have been reported to be caused by L. ivanovii 
that mostly infects ruminants (Guillet et al,. 2010) 
Listeria are Gram -positive rods with low G +C content, unable to form 
capsule or spores, and motile at temperatures between 10 to 25 °C 
(Grundling et al., 2004). Listeria are facultative anaerobic bacteria capable to 
grow at temperatures between 4 to 42 °C, in a broad range of pHs (4.3 - 9.6) 
and salt concentrations (< 10 %) (Collins et al., 1991, Rocourt, 1999). 
Decomposing plant matter is the bacteria natural habit where they live like 
saprophytes, but they can be isolated from different environments such as 
water, soil, animal and human feces and food. 
1.2 Listeria pathogenesis and listeriosis 
The infectious disease caused by Listeria is known as listeriosis. 
Although Listeria can infect healthy adults, it has been described as an 
opportunistic pathogen primarily affecting pregnant women, neonates and 
elderly people. The disease can vary from a non -invasive form, generally an 
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asymptomatic infection restricted to the gastrointestinal tract, to an invasive 
form causing sepsis, and eventually meningoencephalitis and abortion 
(Vazquez -Boland et al., 2001a). 
First cases of human listeriosis were reported in 1929 in Denmark 
(Nyflet, 1929) but the disease at that time was rare. It was not until the 
beginning of the 1980s when listeria was established as an important food - 
borne pathogen, causing epidemic outbreaks in human in North America and 
Europe (Ryser, 1999; Goulet et al., 2001; Roberts & Wiedmann, 2003; de 
Valk et al., 2005; Goulet et al., 2008). 
Listeria infection is often associated with contaminated food ingestion 
(Farber & Peterkin, 1991). Bacteria pass through the stomach to penetrate in 
the host intestinal epithelium (Figure 1) (Nikitas et al., 2011). From there, 
Listeria raises the lymph nods and gets to the primary target organs spleen 
and liver via lymphohaematogenous dissemination (Marco et al., 1992; Pron 
et al., 1998; Bou Ghanem et al, 2012). If the infection is not controlled at this 
point, bacteria can invade secondary target organs such as brain or placenta. 
In those cases there is a high risk of meningoencephalitis, abortion or 
neonatal septicemia (Vazquez -Boland et al., 2001a). 
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Figure 1. Representation of Listeria infection pathophysiology (Vazquéz -Boland et al., 
2001). 
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1.3 Intracellular cycle 
Listeria can invade, proliferate and spread in phagocytic cells and 
many mammalian cell types. Non -phagocytic cells are invaded via specific 
ligand- receptor interactions (Kuhn and Goebel, 2000). 
The intracellular cycle starts with the adhesion and internalization of 
the bacteria into the host cell. L. monocytogenes interacts with a number of 
different eukaryotic receptors including the transmembrane glycoprotein E- 
cadherin (Mengaud et al., 1996), the C1 q complement factor receptor (Braun 
et al., 2000), the Met receptor for the Hepatocyte Growth Factor (HGF) (Shen 
et al., 2000) and components of the extracellular matrix (ECM) (Alvarez - 
Dominguez et al., 1997; Gilot et al., 1999). Ligand- receptor interactions 
induce bacteria internalization by a zipper -type mechanism in which each 
bacterium gradually sinks into host cell pseudopods until it is finally engulfed 
into the cytoplasm (Figure 2a, 2b) (Schubert et al., 2002;Shen et al., 2010). 
Inside the cell, L. monocytogenes is initially enclosed in a phagocytic 
vacuole and avoids lysosome formation by disrupting the phagosome 
membrane. (Figure 2c) (Alvarez- Dominguez et al., 1997; Gaillard et al., 
1987). Thus, Listeria is free in the cytosol and starts the replication phase 
(Vazquéz -Boland et al., 2001). At the same time, L .monocytogenes induce 
actin polymerization and the bacteria became surrounded by a cloud of actin 
filaments. Once the daughter bacteria are detached from the mother, actin 
filaments rearrange in one pole of the bacterium forming the characteristic 
Listeria tails (Figure 2d). Two populations of cross -linked actin filaments 
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conform each tail that propels Listeria in to the cytosol following a random 
circulation known as `rocket movement'. This movement allows the bacteria 
to reach the periphery of the cell and eventually being in contact with the 
plasma membrane to create pseudopod -like structures that protrudes into 
neighboring cells. These protuberances with a bacterium in the top are 
engulfed by phagocytosis, leading to the formation of a double membrane 
phagosome in the adjacent cell (Figure 2e). Then L. monocytogenes 
intracellular cycle starts again with the bacteria escaping from the vacuole, 
replicating and spreading (Vazquez -Boland et al., 2001; Hamon et al., 2006). 
6 
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Figure 2. Intracellular life cycle of L. monocytogenes. (a) L. monocytogenes induces its 
entry into a non -professional phagocyte; (b) bacteria are internalized in a phagocytic 
vacuole; (c) the membrane of the vacuole is disrupted by the secretion of two 
phospholipases, PIcA and PIcB, and the pore- forming toxin listeriolysin O; (d) Bacteria are 
released into the cytoplasm where they multiply and start to polymerize actin, as observed 
by the presence of the characteristic actin tails; (e) actin polymerization allows bacteria to 
move inside the cytosol and eventually pass into a neighbouring cell by forming protrusions 
in the plasma membrane; (f) upon entry into the neighbouring cell, bacteria are present in a 
double -membraned vacuole, from which they can escape to perpetuate the cycle. (Hamon et 
al., 2006). 
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1.4 L. monocytogenes virulence 
All the steps of the intracellular life cycle of L. monocytogenes are 
mainly mediated by only few key virulence factors that are under the control 
of the main virulence regulator PrfA (positive regulatory factor A), which is 
activated upon entry to the host cell. Other bacterial factors as well as gene 
regulators play an accessory role during intracellular life of Listeria, 
enhancing the performance of the bacteria in the host (Scortti et al., 2007; 
Freitag et al., 2009; de las Heras et al., 2011). 
1.4.1 Main virulence factors 
Entry: Internalins 
The internalins (InI) belong to a superfamily of group leucine -rich 
repeat proteins. The genome of L. monocytogenes contains more than 20 inl 
genes which encodes two classes of InI: large /surface attached InI as the 
InIA and InIB; and small /excreted InI exemplified by InIC. InIA and InIB are the 
major listerial factors involved in the entrance to the host cells (Vazquez - 
Boland et al., 2001). InIA binds the transmembrane epithelial protein E- 
cadherin mediating the bacteria gastrointestinal invasion (Mengaud et al., 
1996; Schubert et al., 2002). InIB binds the c -Met receptor and the 
Hepatocyte Growth Factor (HGF) promoting invasion in a broad range of 
mammalian cell types (Shen et al., 2010). It has been recently shown that 
InIB can work synergistically with InIA not only to promote feto- placental 
infection but also accelerating the intestinal invasion (Pentecost et al., 
2010). 
R 
Phagosome disruption: Listeriolysin O and Phospholipases 
Listeriolyisin O, LLO, was the first virulence determinant to be 
identified and sequenced in L. monocytogenes (Jenkins et al., 1964). This 
protein is a streptolysinO- related cytolysin belonging to the family of 
cholesterol- dependent pore- forming toxins (Geoffroy et al., 1987). LLO works 
in a low pH (similar to the one within the phagosome) creating pores in the 
phagosome membrane (Gedde et al., 2000). LLO has a PEST -like sequence 
(P, Pro; E, Glu; S, Ser, T, Thr) present in the N- terminus for a fast 
degradation in the host cell cytosol; thus the bacterium avoids any damage 
that could compromise host cell viability (Decatur and Portnoy, 2000). The 
pores caused by LLO facilitate the action of the listerial phospholipases 
leading to total disruption of the phagosome membrane. It has been recently 
published that LLO is also involved in L. monocytogenes internalization 
(Vadia et al., 2011). 
L. monocytogenes secretes two phospholipases C with different 
substrate specificity: PIcA and PlcB. PIcA is a phosphatidylinositol -specific 
phospholipase while PlcB is a lecithinase with a broad range of substrates 
including phosphatidylcholine, phosphatidylserine and 
phosphatidylethanolamine (Vazquéz -Boland et al., 2001). PIcA is an 
accessory virulence factor that helps LLO and PlcB for the bacteria escape 
from the primary phagocytic vacuole (Smith et al., 1995; Alberti -Segui et al., 
2007). PIcB also has a role dissolving the primary and secondary vacuoles 
independently of LLO activity (Gründling et al., 2003). 
Q 
Movement and cell -to -cell spread: Actin nucleator protein 
The actin nucleate protein, ActA, is a surface -associated protein that 
mediates the actin -based motility of the bacteria promoting cell -to -cell 
spread. ActA activates the actin polymerizing protein complex Arp2 /3 of the 
host cell and the recruiting G -actin (Kocks et al., 1992; Cossart, 2000). ActA 
takes also part in the host cell invasion directing an internalization pathway 
specific for epithelial cells, remodeling the cells microvilli into pseudopods 
that mediates bacterial uptake (Suarez et al., 2001). A recent publication 
shown that ActA also promote bacterial aggregation in the host intestine, 
which is associated with a longer bacterial persistence and shedding through 
the feces, therefore contributing to listerial transmission (Travier et al., 
2013). 
Replication: Hexoses phosphate transporter 
The hexoses phosphate transporter, Hpt, is a permease homolog to 
the mammalian glucose -6- phosphate translocases (G6PT) only present in 
Listeria pathogenic species. Hpt belongs to the organophosphate:inoraganic 
phosphate antiporter family of transporters with homologous in other 
pathogens as Escherichia coli, Salmonella enterica, Shigella flexneri and 
Staphylococcus aureus (Chico -Calero et al., 2002) among others. Hpt 
mediates the uptake of hexoses phosphates from the host cell cytosol 
through a P(i)- linked antiport carrier to boost an efficient listerial intracellular 




PrfA is a member of the (Crp) /fumarate nitrate reductase regulator 
(Fnr) family, specific to Listeria pathogenic species. The core regulon of PrfA 
contains 10 genes, 6 of them clustered in a pathogenicity island (LIPI -1) 
(Milohanic et al., 2003; De las Heras et al., 2011) (Figure 3). PrfA acts as a 
switch that turns on -off the expression of the virulence genes, optimizing the 
fitness of the bacteria when growing either in the infected host or as a 
saprophyte in the environment (de las Heras et al., 2011). The exact 
mechanism of induction is unknown but there is strong evidence that it is 
mediated by allosteric activation of the protein upon binding a co- factor (de 
las Heras et al., 2011; Deshayes et al., 2012). 
LIPI-1 
Figure 3. The PrfA regulon. The PrfA regulon contains 10 genes, 6 of them clustered in the 
Listeria pathogenicity island (LIPI -1): hly, actA, plcA, plcB, mpl and prfA; plus three 
additional chromosomal loci: the inlAB operon and the in/C and hpt monocistrons. Genes 
pointing to the right are on the positive strand. PrfA boxes are indicated by black squares, 
known promoters and transcripts are indicated by `P' and dotted lines respectively (modified 
from De las Heras et al., 2011). 
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1.5 L. monocytogenes intracellular replication 
Within the host cells Listeria replicates in the cytosol with a longer 
doubling time compared with growth in rich medium ( 60 min in J774 cells 
and 20 min in rich medium), nevertheless the cytosol seems to provide 
Listeria with all the necessary nutrients for growth. Although the cytosol is 
considered, in nutritional terms, a rich environment not all intracellular 
bacteria are able to replicate in the cytoplasm as demonstrated by Goetz and 
coauthors (2001). They shown that bacteria non -adapted to live in the cytosol 
as the intravacuolar Yersinia enterocolitica and S. typhimurium were unable 
to replicate efficiently in the cytoplasm when directly placed there by 
microinjection (Goetz et al., 2001). These results suggest that cytosolic 
bacteria require specific adaptations to reach an efficient replication in this 
niche. Thus, one of the clear examples of adaptation is the presence of Hpt 
permease in L. monocytogenes which steal sugar phosphates from the host 
cytosol to fuel fast growth (Chico -Calero et al., 2002). Another example is the 
lipoate ligase LpIA1, which was shown to specifically adquire lipoate from the 
cytosolic lipoyl peptides (Keenay et al., 2007). 
1.5.1 Intracellular carbon related nutrition 
Previous work in our laboratory had shown that L. monocytogenes 
utilize sugar phosphates as a carbon source upon PrfA activation (Ripio et 
a/., 1997). Moreover, Chico -Calero et al. (2002) published that Hpt is required 
for efficient proliferation in host cell and essential for L. monocytogenes full 
virulence in mice. However, mutants lacking the Hpt permease, although 
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impaired in growth (at least twice the doubling time of the wild -type strain) 
can still proliferate in the host cytosol despite they are unable to use sugar 
phosphates (Figure 4) (Chico -Calero et al., 2002). These data suggests that 
L. monocytogenes uses other cytosolic nutrients as carbon sources while 
utilizing hexoses- phosphate as an additional source of carbon for a rapid 
intracellular growth. 
Recent studies carried out in Vazquez -Boland's laboratory using Hpf 
and Hpt+ Listeria shown that the intracellular proliferation defect of Hpf 
bacteria was only evident when the host cells were kept at or below 
physiological concentrations of glucose 5mM) but not when glucose was 
added at higher concentration to the culture media (25mM) (Figure 5). They 
also observed that when the host cell was deprived of glucose L. 
monocytogenes did not proliferate whereas other intracellular bacteria as S. 
enterica and S. aureus were not affected in growth. Therefore, taking 
together these data it was suggested that Listeria depend on a glucose - 
derived carbon source for intracellular growth and that the non -sugar 
phosphate based growth (Hpf) is supported by free glucose or a metabolite 
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Figure 4. Effect of the Hpt mutation on the intracellular replication of L. 
monocytogenes in mammalian cells. Human colon epithelial cells (Caco -2), human liver 
hepatocellular carcinoma cells (HepG2) and mouse monocyte macrophages (J774) were 
infected with Hpt+ and Hpt. Results are the mean of at least three independent experiments 
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Figure 5.Effect of different intracellular glucose concentrations on the L. 
monocytogenes Hpt and Hpt+ replication in rat hepatoma FT02B cells. Results are the 
mean of at least three independent experiments (each performed in duplicate) ± SE 
wt/ Hpt+ if /0 ) and Ahpt/ Hpt (A /o ). IMM+ 5mM glucose are physiological conditions 
(Lecharme -Lora, PhD thesis, 2007). 
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1.5.2 Transport of glucose in L. monocytogenes 
Non -phosphorylated sugars are uptaked by Listeria via the 
phosphoenolpyruvate (PEP):carbohydrate phosphotransferase system (PTS) 
or through the non -PTS permeases (Parker and Hutkins, 1997). 
PTS is a complex transport system integrated by several proteins, 
usually five, that transport and phosphorylate carbohydrates using the PEP 
as a phosphoryl donor (Kundig et al., 1964). In Listeria the system is 
redundant with 86 pts genes encoding 29 complete PTSs (Barabote and 
Saier, 2005; Stoll and Goebel 2010). The system consists basically of two 
cytoplasmic sugar un- specific proteins: HPr and enzyme I (El), and the 
membrane -associated enzyme Il (Ell) complexes specific for one or few 
sugars. The Ell complex consist of 3 to 4 proteins or domains: EllA, EIIB, 
EIIC and EIID. The phosphoryl group is transferred from the PEP to El, HPr, 
EllA, EIIB and finally to the sugar transported via the EIIC component 
(Mertins, 2007) (Figure 6). The phosphorylated sugar remains inside the 
bacteria. Depending on the Ell complex type, PTS permeases can be 
subdivided into seven families: PTSGIC, PTSMa" PTSLa °, PTSFr", PTSa"t, 
PTSGat and PTSASC (Barabote and Saier, 2005). The seven families are 
present in L. monocytogenes where PTSMan -2, PTSMan -3 and PTSGIc -' are the 
main permeases involved in the glucose up -take, although with different 
efficiency (Stoll and Goebel, 2010). 
L. monocytogenes also encodes a low- affinity glucose transport 
system in which the internalization of glucose is probably driven though 
15 
permeases by the proton motive force (PMF) (Christensen and Hutkins, 
1994). Recent work from Aké et at (2011) described three genes encoding 
three low- affinity non -PTS glucose transporters GIcU1, GlcU2 and GIcU3, 
homologues to those of S. xylosus and Lactococcus lactis. Their studies 
revealed that the low affinity glucose transporters do not contribute 
significantly to the glucose uptake. The function of these transporters was 
described as accessory and no effect in the bacteria growth has been 
observed when each gene was deleted. 
Sugar 
0000 00000 00 
Figure 6. Schematic representation of the PTS system. The PTS is composed of five 
distinct proteins: the enzyme II complex (Ell) that consists of three proteins: EllA, EITB, ETIC; 
protein (HPr); and enzyme I (El) (Nancy et al., 2009). 
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1.6 Justification and objectives 
Infection due to L. monocytogenes, although has lower incidence 
compared with another foodborne diseases such as salmonellosis, has a 
high overall fatality rate of 20 -30 %, reaching 70% in untreated neurologic 
cases and 50% in infected newborns. The intracellular location of listeria on 
one side hide the pathogen from the immune system and, on the other side 
make difficult to treat the infection because only few antibiotics are able to 
reach the cell cytosol at high concentration. 
An important step in the infection process is the adequate replication 
of the parasite to increase the bacterial load and eventually produce disease 
and spread to a new host. A better understanding of L. monocytogenes 
nutritional requirements in vivo and the mechanisms that the bacterium uses 
to grow intracellularly could signify a revolution related to new treatments 
against listeriosis. 
As mentioned before (Section 1.5) Listeria utilize sugar phosphates 
from the host's cytosol to promote intracellular growth, however in the 
absence of sugar phosphate transport the bacteria, albeit slow, are able to 
growth intracellularly. Preliminary work from Vazquez -Boland's group 
indicates that Listeria utilizes free glucose from the host cytosol as a source 
of carbon to enable growth (see Section 1.5.1). The aim of this thesis is to 
further explore the utilization of cytosolic free glucose as a carbon source for 
listerial growth. 
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More specifically, the objectives of this Master by Research thesis are: 
1. To obtain more direct evidence that glucose -or an early intermediate 
of the glycolitic pathway- is the main carbon source for L. 
monocytogenes inside the host cell. 
2. To assess the role of the PTS system and the non -PTS glucose 




Role of glucose transporters during intracellular listerial 
replication 
L. monocytogenes uptakes glucose and another non -phosphorylated 
sugars mainly via the PTS system (Stoll and Goebel, 2010). In Listeria this 
system is redundant to the extent that 3.2% of all L. monocytogenes genes 
encode PTS proteins (Barabote and Saier, 2005). Recently, Stoll and Goebel 
(2010) had shown that in L. monocytogenes PTSMan -2, PTSMan -3 and PTSGc-1 
are the main PTS systems involved in the uptake of glucose. L. 
monocytogenes mutants lacking those transporters are severely impaired 
during in vitro growth under low glucose concentrations (< 2mM). However 
Stoll and Goebel (2010) did not observed any effect during intracellular 
replication in the AptsMan, ptsGic -1 mutant (defective in all four PTSMan and 
PTSG10-1 permeases). 
Given the redundancy of these transporters in L. monocytogenes and 
the lack of precise knowledge about the regulation of the different PTS 
transporters under different conditions we decided to use a mutant in the 
common PTS proteins to analyze the contribution of the glucose to the 
listerial intracytosolic growth. A L. monocytogenes AptsH mutant lacking 
functional phosphoryl donor protein HPr was already available in our 
laboratory. Mutants in the general PTS proteins had been reported to have 
an impaired growth in vitro when glucose is the only carbon source present in 
the culture media, however they never been tested in in vivo conditions 
(Mertins et al, 2007, Stoll and Goebel, 2010; Aké et al., 2011). 
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Recent publication from Aké and collaborators (2011) suggested that 
the non -PTS glucose transporters GIcU could be responsible for the glucose 
uptake in absence of a functional PTS system, although single mutants 
defective in the three GIcU transporters did not show any effect in the 
bacteria in vitro growth (Aké et al., 2011). 
In order to obtain bacteria totally impaired to grow in glucose, a 
disabled mutant in GIcU1 (main GIcU transporter) was generated by plasmid 
insertion on L. monocytogenes AptsH (already lacking PTS transport). 
2..1 Construction and characterization of ptsH, g &cUl mutants in L. 
monocytogenes 
All the bacterial strains used in this project are summarized in Table 1, 
section 5.1.2 Materials and Methods. 
L. monocytogenes AptsH in -frame deletion mutant was obtained by 
double homologous recombination and it was already available in Vazquez - 
Boland strain collection. Single insertion mutant glcU1::pAUL -A and double 
mutant AptsH,glcUl::pAUL -A were generated by disruption of gicUl gene 
through the insertion of pAUL -A plasmid (Material and Methods, Section 
5.2.3). 
We complemented AptsH using a modification of the site -specific 
shuttle integration vector pPL2 (Materials and Methods, section 5.2.4). The 
phenotypic characterization of AptsH(pPL2P3ptsH) didn't show any 
difference with the parental strain (Section 2.1.2, Tables 6 to 10) and its 
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intracellular replication did not differ from the native wild type. That showed 
the function of the ptsH gene has been restored, probing that the decrease in 
the proliferation levels of AptsH strains was caused exclusively by the lack of 
ptsH gene. We found no need to complement the gene glcU9 because we 
couldn't find significant differences between intracellular g /cU1::pAUL -A and 
the parental strain. 
A phenotypic characterization of each strain was performed to exclude 
any defect in the activity of PrfA that may influence the virulence of the L. 
monocytogenes mutant strains. To this end, we analyzed the phenotype 
using two natural reporters of the PrfA funtionability: PIcB and Hpt. The 
analysis of Hpt allows us also to rule out any defect in the transport of HPs 
that can impair the bacteria growth inside the host cell. 
The activity of the PIcB was tested by restreaking the bacteria in 
lecithin plates with and without 0.5% activated charcoal supplementation 
(Material and Methods, Section 5.4.2). L. monocytogenes hydrolyze the 
lecithin present in the medium through the action of the PrfA- dependent PIcB 
phospholipase developing a visible opacity halo around the bacteria streak. 
During in vitro listerial growth PrfA- dependent genes are weakly expressed 
and therefore no precipitation halo is observed. However, when activated 
charcoal is present, the PrfA system is upregulated (Ermolaeva et al., 2004) 
and the halo is observed around the strains. All the mutant strains behaved 
similar to the parental strain, showing a halo only when the charcoal was 
present in the media and the PrfA became active (Figure 7). 
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The activity of the Hpt was tested using a sugar -phosphates 
fermentation assay (Figure 8). This test is based on the pH meter capacity of 
the phenol red broth that changes its colour from red to yellow when the 
bacteria utilize the sugar generating acids that decreases the pH. hpt, as 
another PrfA- dependent virulence factor, is only expressed when PrfA is 
active and therefore the test was carried out using media with and without 
active charcoal. The results were the same for all the tested strains (Table 1, 
section 5.1.2 Materials and Methods): while phenol -red test was negative 
(red) because Hpt was not able to transport the HP sugar, The phenol -red 
charcoal test was positive (yellow) showing that when the PrfA system gets 







Figure 7. PrfA phenotype based on lecithinase activity. A) Lecithin plate B) Lecithin + 
charcoal plate. Halos show the lecithin hydrolyzation and therefore corresponds to the 
activity of PrfA. A Halo around bacteria is observed for PrfAWT phenothype; Bigger halo is 
observed when PrfA is over expressed (PrfA* phenotype) and no halo is observed for PrfA- 
phenotype. Experiment control phenotype: PrfAWT (1), PrfA* (2), PrfA- (3). Strains to test: 




Figure 8. Hpt phenotype based on fermentation capacity. A) Phenol red + charcoal B) 
Phenol red. A change in the color from red to yellow is observed for strains with a functional 
hpt. Strains to test: L ptsH(pPL2- P6ptsH) (1), dptsH (2), WT (3), LptsH,g1cU1::pAUL -A (4) 
and IcU1:: pAUL -A (5). Experiment control phenotype: PrfA THpf (6), PrfA *Hpt %T (7), 
PrfA HptWT(8). 
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2.1.2 Effect of single and double mutation on in vitro growth 
Six different broths were used in this phenotypic characterization, 
growing every strain during 24h and 48h and taking measures of the optical 
density at 600 nm (0D600) every 30 minutes. Three preliminary experiments 
were performed using laboratory routine media Brain Heart Infusión media 
(BHI), Luria -Bertani (LB) and LB supplemented with 20mM glucose. BHI is a 
sugar -reach media use to grow Listeria in an everyday laboratory work, while 
LB is a media poor in glucose where L. monocytogenes struggles to grow. By 
doing this first experiment, we wanted to compare the growth of the different 
strains (trying to find differences from the wild type) by the addition of 
glucose to the poor glucose media LB. 
In BHI (Figure 9A), the single mutant for the non -PTS glucose 
transporter GIcU1 (g /cU1::pAUL -A) grew as well as did the parental strain 
EGD. Only the single mutant in the PTS system (AptsH) and the double 
mutant for the PTS system and the non -PTS transporter GIcU1 
(AptsH,g/cUl::pAUL -A) had a considerable delay in their growth. AptsH 
reached wild type growth levels after 20h (OD600 of 1.2 -1.4), 
AptsH,glcUl::pAUL -A showed a slight growth reduction even after 24h of 
incubation (OD600 of 1). 
In LB (Figure 9B), were the growth is lower than in BHI, the growth of 
the double and single mutant strains AptsH and AptsH,glcUl::pAUL -A was 
specially affected. These two strains had a long log phase and their growth 
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was delayed 15h compared with the wild type strain. 
When glucose was added to the LB broth (Figure 9C), the growth of 
LptsH and AptsH,g1cU1::pAUL -A was highly delayed (5h and 15h 
respectively) but reaching wild type growth levels after 24h. 
BHI and LB are still complex media that contain a mix of carbon 
sources that could interfere in our study of L. monocytogenes glucose -related 
growth. In order to determine the role of PTS and GIcU1 in the glucose 
uptake and the effect of their lack in the in vitro growth of L. monocytogenes, 
we decided to characterize the strains in the chemically- defined media IMM 
(Improved Minimal Media; Phan -Than and Gormon 1997) (Figure 10). Using 
this media turned out to be very variable from one experiment to another 
because every batch of IMM was giving different OD values. However, similar 
behaviour patterns of the strains were appreciated in each experiment. 
The IMM assay corroborates previous results found in the routine 
medias, showing a much more marked difference in the growth of the 
glucose transporters mutants comparing with the rest of the strains when 
growing them in the presence of glucose as the only available carbon source 
(Figure 10A). Under these conditions, we saw that the wild type strain and 
the single mutant for the non -PTS glucose transporter g /cU1::pAUL -A could 
reach maximum OD values of 1.8 -2.0 after 22 -26h. The growth of dptsH and 
LptsH,glcUl::pAUL -A strains was extremely delayed (14h and 24h 
respectively), to the point of not seeing AptsH,glcUl::pAUL -A reaching wild 
type levels even after 48h of incubation. However, by growing the Listeria 
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strains in IMM with uridine as an alternative carbon source (Figure 10B), we 
observed that all the strains (including mutants AptsH and 
dptsH,glcUl::pAUL -A) grew similarly reaching OD levels 0.6 -08. 
Our results probe that AptsH and dptsH,glcUl::pAUL -A are able to 
metabolise other carbon sources as efficiently as the wild type does, 
discarding faults in the bacteria carbon metabolism and showing that the only 
explanation for the delay /decrease in the growth of these strains is their 
inefficient glucose transport. 
No growth was observed for any of the Listeria strains when no source 
of carbon was added to the IMM (Figure 100). That corroborates previous 
experiments in chemical defined media that showed the impossibility of L. 
monocytogenes to grow in vitro without a solid carbon source (Premaratne et 
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Figure 9. Representative L. monocytogenes in vitro growth curves in different medias: 
Strains EGD (wt), LlptsH, LtptsH(pPL2- PòptsH) ,g /cU1::pAUL -A and LptsH,glcUl::pAUL -A 
were grown in BHI (A), LB (B) and LB supplemented with glucose (C), At least three 
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Figure 10. Representative L. monocytogenes in vitro growth curves in supplemented 
IMM: Strains EGD, AptsH, LlptsH(pPL2- PóptsH) ,g /cU1::pAUL -A and AptsH,glcU1::pAUL -A 
were grown in IMM supplemented with glucose (A), IMM supplemented with uridine (B) and 
IMM (C) for 48h. 
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2.1.3 Intracellular growth of L .monocytogenes glucose transporters 
mutants in HeLa cells 
2.1.3.1 Intracellular proliferation 
We performed an infection assay in cell monolayers to see if the 
bacterial intracellular growth was also altered due to mutations in the glucose 
transporters. 
Proliferations in HeLa cells grown in 25mM glucose DMEM were 
performed using the gentamicin exclusion assay: Listeria- infected HeLa cells 
were exposed to a bactericidal dose of gentamicin after 1h infection (time 
zero, to) and during the rest of the assay. This antibiotic is unable to 
penetrate inside the cell, so it will only act killing bacteria in the extracellular 
medium. Thus, an enumeration of the intracellular bacterial population can 
be made by plating infected -HeLa lysates and counting the number of colony 
forming units (CFU). Bacteria moiety of infection (MOI) was adjusted in each 
case to get the same number of intracellular bacteria at to We used IGC (the 
intracellular growth coefficient) to normalise the intracellular bacterial growth 
data for the bacterial population at t = O. 
The results (Figure 11A) showed that L. monocytogenes OptsH and L. 
monocytogenes AptsH,glcU1::pAUL -A had severely impaired their 
intracellular proliferation capacity: while wild type proliferation ratios reach 
IGC at t = 8 values of 179.68 ± 3.32, we could barely see proliferation for the 
single and double mutants at 8h (IGC 0.39 ± 0.11 and 0.45 ± 0.02 
respectively). Generally Listeria intracellular proliferations are performed only 
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during 8h. However we wanted to check if AptsH and AptsH,glcUl::pAUL -A 
had the same growth behaviour as in in vitro conditions, showing a delay at 
14h and 24h respectively but eventually reaching wild type intracellular 
levels. 
At 48h (figure 11B), the difference between the wild type strain (IGC of 
3448.1 ± 953.1), AptsH (IGC of 75.2 ± 58) and AptsH,glcUl::pAUL -A (IGC of 
1.9 ± 1.8) was even bigger. Since our results showed strains lacking ptsH are 
affected in the intracellular growth, we decided to complement LptsH to 
discard an impaired intracellular growth due to faults in another regions of the 
Listeria genome. 
A Student's t -test was performed to analyse the proliferation data 
(figure 12) and only significant differences were found between the wild type 
and AptsH and AptsH,glcUl::pAUL -A (p <0.05 at 8h and p <0.01 at 24h). 
There were no significant differences when comparing any other tested strain 
with the wild type and also no differences were found in the proliferation 
capacity of AptsH and AptsH,glcUl::pAUL -A at any time (t =0.20; p =0.84 at 
time 8h and t =1.6; p =0.15 at 48h). 
Taking into account the significant decrease in AptsH and 
OptsH,pAUL- A::GIcUl proliferation levels and previous experiments showing 
no fault in the bacteria virulence factors and neither in their carbon 
metabolism, we assumed that the decrease in the proliferation levels was 
caused by an inefficient glucose up -take. 
31 
However, It has been previously published that pathogenic Listeria 
requires being in the host cell cytosol to replicate and strains lacking 
functional PrfA and other virulence factors such as LLO have been shown to 
have an inefficient replication (and subsequently less proliferation levels) 
(Gedde et al., 2000, De las Heras et al., 2011). We then decided to 
microscopically test AptsH and AptsH,pAUL- A::GIcU1 to check their ability to 
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Figure 11. Intracellular proliferation of L. monocytogenes EGD, in HeLa cells. 
IGC values for wild type EGD, g /cUl::pAUL -A, AptsH, AptsH(pPL2- P5ptsH) and 
AptsH,glcUl::pAUL -A in a 48h proliferation assay (A). Focused IGC values for AptsH and 
AptsH,glcUl::pAUL -A are shown in figure B. Data are mean values of four independent 
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Figure 12. Statistical analysis for L. monocytogenes proliferation in HeLa cells. 
Multiple Student's t tests for the IGC values were performed at 8h (A) and 48h (B). Data are 
mean values of at least three independent experiments ± SE. ( *) means t- values with a 
p <0.05. ( * *) means t- values with a p <0.01. 
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2.1.3.2 Visualization of cytosolic bacteria 
Immediately after disrupting the phagosome, a cloud of actin filaments 
starts surrounding L. monocytogenes (Vazquez -Boland et al., 2001). We 
tested the ability of the mutants AptsH and AptsH,glcU1::pAUL -A (whose 
proliferation has seen to be severely impaired) to reach the cytosol. For that 
purpose, an actin -association staining was carried out in HeLa cells infected 
with the Listeria strains to test. 
The host cell actin was stained with phalloidin conjugated with a 
fluorescent dye and we used DAPI to stain the DNA from the bacteria and 
cell nuclei. We then colocalized bacteria and actin using a fluorescent 
microscope (Deshayes et al., 2012). Phalloidin is a fungus toxin extracted 
from Amanita phalloides that binds specifically at the interface between F- 
actin subunits. DAPI (4',6- diamidino -2- phenylindole) is a fluorescent stain 
commonly used in microscopy to dye DNA. This compound passes through 
the cell membrane and binds strongly to A -T rich regions in DNA. Using both 
phalloidin and DAPI, we could visualize the cell cytoskeleton and the actin 
halos around baceria (stained by phalloidin) and the nucleus of bacteria and 
cells (stained by DAPI). L. monocytogenes Ahly was used as a negative 
control due the incapability of this mutant (lacking in the production of LLO) to 
escape efficiently from the vacuole (Gedde et al., 2000). 
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Figure 13. Detection of L. monocytogenes actin 
recruitment. HeLa cells were infected with L. 
monocytogenes: A) WT, B) Ahly , C) AptsH, D) 
g/cUl::pAUL-A and E) LptsH (pPL2PÖptsH). 
Cells were then fixed and stained with DAPI (white) 
and phalloidin (red). Actin association around 
cytosolic bacteria was observed 4h after infection 
and zoom in the bottom left square of each picture. 
Data for each time point are the mean percentage 
of five microscopic fields per experiment, and three 
independent experiments. Images were originally 
captured at 630 X magnification. 
The images (figure 13 and 14) showed that there is not a significant 
difference in the vacuole escape between the wild type, the single mutants 
LptsH and g /cU1::pAUL -A and the complemented strain AptsH(pPL2- 
P5ptsH), suggesting that AptsH had the same escape and actin recruitment 
capacity as the wild type phenotype. Although we were not able to find 
intracellular AptsH,glcUl::pAUL -A bacteria at the time of the measurement, 
the proliferation assay probed the existence of intracellular 
íptsH,glcUl::pAUL -A, showing the same number of initial bacteria as the 
other strains after 30 minutes infection. The results for this strain were 
inconclusive, suggesting that the experimental conditions should be further 
optimised. 
Figure 14. Percentage of intracellular bacteria associated with actin. The panel presents 
the quantification of the intracellular bacteria that recruit actin (mean %± SEM %). Student's t 
tests were performed on the results of 3 independent experiments showing a significant 
difference only between the wild type strain and the mutant in the LLO protein (Dhly). ( *) 
means t- values with a p <0.05. ( * *) means t- values with a p <0.01. 
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Glucose dependence of L. monocytogenes intracellular 
growth 
Our previous results are a direct evidence of the importance of 
glucose in the intracellular metabolism of L. monocytogenes. In order to 
provide new evidence about the essential role of free intracellular glucose in 
L. monocytogenes growth, we decided to use a different strategy modifying 
the conditions inside the HeLa cells (host model) instead of using L. 
monocytogenes glucose uptake defective strains. 
Previous experiments in Vazquez -Boland group (Lecharme -Lora, 
2007) determined that there was a growth difference between the wild type 
strain (Hpt +) and the mutant in the HPs transporter (Hpt-) at physiological 
concentration of glucose (z, 5mM). They also discovered that increasing the 
concentration of glucose inside the cell to z 25mM, both strains reached 
similar growth levels (Lecharme -Lora, 2007) (Figure 15). With these data, 
they proposed a model in which at physiological conditions, all the glucose 
inside the cell is phosphorylated to be then metabolised explaining why Hpf 
grows less than Hpt+ (Figure 15A). But when the system is saturated of 
glucose not every molecule can be quickly phosphorylated, therefore inside 
the cell there will be free of glucose that Hpf can use to grow on the same 
way the wild type Hpt+ does (Figure 15B). 
In order to obtain a pool of free glucose inside the cell at physiological 
conditions, they decided to deplete HeLa cells hexokinases (HK) by using an 
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non -specific inhibitor: 3- bromopyruvate. HKs phosphorylate glucose forming 
G6P as one of the first steps of the glycoltic pathway. Inhibiting the action of 
these enzymes, no glucose will be broken down and it will accumulate inside 
the cell. Then, they performed a parallel experiment using both strains Hpt+ 
and Hpf in physiological conditions with and without the inhibitor. 
Results for that experiment show that while the Hpf growth had 
increased in the presence of the inhibitor, Hpt+ growth had decreased (figure 
15C). That suggests that in the absence of G6P, the wild type doesn't have 
the advantage of an additional source of carbon for a rapid intracellular 
growth, therefore its intracellular proliferation values are lower than in normal 
cellular conditions. On the other hand, Hpf that in normal conditions doesn't 
have enough intracellular glucose to reach wild type proliferation levels, finds 
a high glucose- concentrated cytoplasm that can use to meet its nutritious 
requirements nearly reaching wild type intracellular growth levels (figure 
15C). However, there is still a difference between the Hpt+ and Hpf 
intracellular growth in the presence of the inhibitor, what drove them to think 
that the inhibition of the HKs could have been incomplete, thus less free 
glucose was available in the cytosol for Hpf to use it. 
In this project we sought to see if there is still a difference between 
Hpt+ and Hpf intracellular replication in cells that have been HK- silenced by 
using a specific inhibitor. Small interference RNA (siRNA) was selected to 
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Figure 15: Intracellular growth of L. monoctogenes depends on glucose and G6P 
availability. A) At physiological conditions HeLa cells uptake and immediately transform 
glucose into G6P (right panel, schematic representation). In this situation L.monocytogenes 
Hpf grows less than wild type Hpt+ (left chart). B) When the system is saturated of glucose 
not every glucose molecule can be transformed and an intracellular pool of free glucose 
appears (right panel, schematic representation). Then, Hpf and Hpt+ use that glucose as a 
carbon source growing at the same level (left chart). C) Using the HK inespecific inhibitor: 3- 
bromopyruvate a intracellular pool of glucose was generated at physiological conditions 
(right panel, schematic representation). Hpf growth increases in the presence of the inhibitor, 
while Hpt+ growth decreases (left chart). (Lecharme -Lora, 2007) 
40 
2.2.1. Intracellular concentration of glucose and glucose -6- 
phosphate after Hexokinase depletion in HeLa cells. 
Chosen siRNAs were transfected into HeLa cells using lipofectamine 
2000 as a transfection reagent. Lipofectamine 2000 works interacting with 
the siRNA forming unilamellar liposomes that are able to enter inside to cell 
by endocytosis releasing the nucleic acid into the cytoplasm (Dalby et al., 
2004). Once inside the cells, siRNA forms a ribonucleic -protein complex 
called RISC (RNA- induced silencing complex). RISC first mediates the 
unwinding of the siRNA duplex and then it mediates the binding of the single 
stranded siRNA with HK mRNA (targeted mRNA) in a sequence specific 
manner. This binding mediates targeted mRNA cleavage by an unidentified 
endonuclease and the resulted mRNA fragments are then recognized by the 
cell as been aberrant and they are destroyed (Figure 16). This prevents 
translation from occurring, silencing the expression of the HK gene. 
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Figure 16. Schematic representation of the siRNA action (Santa Cruz biotechnology, 
inc) 
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2.2.1.1 Optimisation of the HK depletion using siRNA 
A bibliographical search was performed in order to establish the 
number of HKs that have been described and characterized up to the date. in 
the literature, four HKs were described (Wilson 2003; Sui and Wilson, 2004; 
Rodríguez -Enríquez et al., 2009) and we probed the presence of all of them 
in our HeLa cells by a western blotting assay (Figure 17A). The antibodies 
required to develop this technique were described in Section 5.4.5 (Table 5), 
Materials and Methods. 
We decided to use a pool of four siRNAs per HK in order to increase 
the chances of a complete HK depletion. We did a preliminary experiment 
transfecting HeLa cells with each HK -siRNA cocktail separately to check the 
depletion effect on every HK separately. Then, HeLa cells were transfected 
with the sixteen siRNAs together to see the total impact in the cells (figure 
17.B). We could appreciate that HK1, HK2 and HK3 were completely or 
nearly completely silenced when using the specific pool per HK or the four 
pools together. Although the glucokinase (GCK) couldn't be completely 
depleted, we saw a decrease in the expression of the protein. 
Being sure about the effect of the siRNA on the cells, we decided to 
investigate the proliferation of wild type L. monocytogenes (Hpt +) and the 
mutant lacking functional Hpt (Hpt ") in siRNA -depleted HeLa cells. The 
experimental set -up consisted of obtaining a balance in which at z5mM 
glucose media (physiological conditions), the cells appeared healthy whilst 
the siRNA was effective. To achieve this, we tested different conditions 
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(Figure 18). We finally performed a 4h transfection in standard DMEM media 
(25 mM glucose) followed by a media replacement, using DMEM 5mM 



















Figure 17. Detection of the glucokinase (GCK) and hexokinase (HK) proteins by 
western blot: A) Detection of the HK1, HK2, HK3 and GCK in HeLa cell extracts. The 
concentration of antibody used and the protein weight are specified in each case. A) 
Detection of the siRNA action: Each HK was individually targeted using four different siRNA 
(gel lanes two to four); gel lane five is a combination of the 16 siRNAs use in total to target 













































































































































































































































































































































































































































































































































































































































































































2.2.1.2 Determination of the intracellular concentration of glucose and 
glucose -6- phosphate. 
Once the experiment conditions were set up, the intracellular glucose 
and G6P concentration of the HeLa cells treated with siRNA was measured 
to verify the existence of a free glucose pool inside of them departing from 
physiological concentrations. 
We used a method previously described by Lacharme -Lora (2005), 
based on the estimation of the total cell -volume of HeLa cells described by 
Reitzer et al. in 1979. They showed that there were 0.64m1 of intracellular 
water per 120 mg of cell protein. Thus, measuring the total amount of 
glucose and protein in the sample we could estimate the concentration of 
glucose and G6P inside HeLa cells. In each of three experiments that we 
performed, the cell volume per sample was similar, with values in most of the 
cases around 0.001 ml. However, there was a clear difference in the levels of 
glucose (measured in mmols) between the samples, being higher in the cells 
treated with the HK siRNA (Appendix table1). 
A Student's t -test was performed to analyse the difference in the 
intracellular glucose and G6P concentration between HeLa cells treated with 
HK- siRNA, with si- control and no treated cells. The results showed that for 
HeLa cells pre- treated with HK- siRNA, the glucose concentration was 
significantly higher (p= 0.018) than the concentrations found in both no 
treated or treated with the siRNA control cells while G6P levels were very 
significantly lower (p= 0.007). That shows that HK- siRNAs silenced HKs 
expression avoiding the phosphorylation of the glucose into G6P and 
creating in turn an accumulation of glucose inside the cells. 
Figure 19. Levels of glucose and G6P inside HeLa cells pre- treated with HK siRNA 
(siRNA). The figure shows concentration (expressed in mM) of glucose and G6P expressed 
(mean ± SEM) in HeLa cells treated with a commercial siRNA control (neg siRNA) and non - 
treated (no siRNA), were used as a controls for the experiment. Student's t tests were 
performed on the results of 3 independent experiments showing significant ( *, p <0.05) and 
very significant ( * *, p <0.001) differences in the glucose and G6P concentration of HeLa 
treated with siRNA comparing with untreated cells and cells treated with the siRNA control. 
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2.2.2. Effect of the intracellular glucose concentration on Hpt- 
dependent listerial growth in HeLa cells. 
Finally, HeLa cells pre- treated with siRNA infected with wild type L. 
monocytogenes (Hpt +) and the mutated strain (Hpt "). Listeria proliferationsin 
HeLa cells were performed using the gentamicin exclusion assay as 
described in previous section 2.1.2.1, MOls for each strain were adjusted in 
each case to get the same number of intracellular bacteria at time Oh. 
Proliferation time was 6h and the results are shown as % IGC where the 
value obtained for the wild type strain is taken to be 100 %. A Student's t -test 
was performed to analyse the difference in the intracellular growth between 
Hpt+ and Hpf in the presence of HK -siRNA or siRNA control. 
The results (Figure 20) showed that during the intracellular 
proliferation in the presence of the control siRNA, Hpt+ ( %IGC at t =8 
± 16.7) grew significantly more (p= 0.0047) than Hpf ( %IGC 37.7 ± 9.4). 
However, when the cells were treated with HK- siRNA, Hpf showed wild type 





Figure 20. 6h Intracellular proliferation of L.monocytogenes in HeLa cells pre- treated 
with HK siRNA (si -HK). Hpt+ (WT) appears in grey and Hpf appears in white. HeLa pre - 
treted with a commercial siRNA control (si- control) were used as a controls for the 
experiment. Mean of three independent experiments ± SEM. results are shown as % IGC 
where the value obtain for the wild type strain is taken to be 100 %. A Student's t -test was 






Intracellular parasites adapt their metabolism to the host cell life cycle 
in order to survive and proliferate. The understanding of metabolic changes 
has become an active area of research, as interfering in the pathogen 
nutrient -uptake process could mean a new and more effective way of treating 
the disease (Muñoz -Elias and McKinney, 2006; Eisenreich et al., 2010). 
Every pathogen is different and so is the way it interacts with its host 
cells. The intracellular pathogen M. tuberculosis completely changes its 
nutritional requirements on entry into the host. Intracellular M. tuberculosis 
utilises fatty acids as a carbon source, in contrast its in vitro growth is based 
on a carbohydrate metabolism (Weddel, 2010; Russell, 2011). The Food - 
borne pathogen S. typhimurium secretes a set of effector proteins into the 
host modifying the cell functions for its own benefit (Agbor & McCormick, 
2013). Although glucose has been described to be its preferred extra- and 
intracellular carbon source, S. typhimurium is capable of switching to the 
glycerol metabolism pathway when required (Goebel and Gotz, 2010; Kim et 
al., 2013). 
It is well known that Listeria uses glucose or an early metabolite of the 
glycolitic pathway as its main carbon source under extracellular conditions 
(Tsai and Hodgson, 2003; Schneebeli and Egli, 2013). However, intracellular 
Listeria parasitises the host cell metabolism using hexose- sugars already 
phosphorylated by the host. Chico -Calero (2002) and collaborators described 
these hexose -phosphates as extra fuel for efficient intracellular proliferation, 
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but not essential for Listeria intracellular replication. Other carbon sources 
such as glycerol (Joseph et al., 2008) or glucose (Lacharme -Lora, 2007) 
have been proposed as the main intracellular source of carbon for the 
bacteria. 
Previous results from Vazquez- Boland laboratory suggested an 
important role of glucose in Listeria intracellular proliferation (Lacharme -Lora, 
2007). In order to clarify the real effect of cytosolic free glucose in listerial 
intracellular replication, we carried out experiments using L. monocytogenes 
mutants defective in glucose high /low- affinity transporters PTS system and 
GIcU1 permease. 
Glucose up -take through the PTS system is not specific to Listeria but 
occurs often among bacteria (Barabote and Saier, 2005). Other food -borne 
pathogens such as the enteroinvasive E. coli (EIEC), Shigella flexn (S. 
ffexineri) (that act similarly to Listeria escaping from the phagosome to 
actively replicate in the cytoplasm) also use PTS as main glucose up -take 
system under intra /extracellular conditions (Gotz and Goebel, 2010). An 
insertion mutant defective in the ptsH gen (enconding Hpr protein, a central 
component of all PTS pathways) was described by Mertins et al. (2007). 
Their in vitro experiments measuring the effect of the PTS- mutation on the 
virulence genes PrfA- regulated, showed an induction of those genes when 
the glucose uptake via PTS was impaired. Stoll and collaborators (2008) 
supported Mertins et al.'s findings suggesting that PTS sugars had an 
inhibiting effect on the PrfA under in vitro conditions. However, in our 
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experiments proliferating L. monocytogenes in HK- depleted HeLa cells, there 
was no significant difference proliferating listeria in cells with a high 
intracellular glucose concentration (due to a siRNA HK- depletion), comparing 
with the proliferation levels in cells at physiological conditions. We have also 
proliferated AptsH inside HeLa cells and our results showed a high significant 
decrease in the growth levels of the mutant compared with the parental 
strain, suggesting that listeria requires glucose for its intracellular replication. 
We described for the first time a double mutant lacking both PTS and 
GIcU1 (non -PTS glucose pearmease). The proliferation of this strain in HeLa 
cells was (as AptsH intracelluar growth) completely impaired. This 
corroborates our previous result obtained with AptsH and is direct evidence 
of the importance of glucose for intracellular Listeria. The proliferation of the 
single mutant for the GIcU1 pearmeases was the same as the wild type; only 
the strains lacking ptsh were affected in the intracellular growth. Therefore, 
based on this evidence we propose that the PTS system is the main glucose 
transporter for intracellular listeria. Our in vitro characterization of the single 
mutants for PTS and GIcU1 permeases and the double mutant PTS" GIcU1" 
determined that the PTS system is the main glucose transporter also in vitro 
corroborating previous results of (Stoll and Goebel, 2010). When the glucose 
uptake through the PTS system is active, GIcU1 function is hidden. However 
when the bacteria are defective in both transporters, PTS cannot balance the 
lack of GlcU1 and the activity of the low- affinity glucose transporter comes to 
light. 
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To provide further evidence for this conclusion from the host cell side, 
we proliferated Hpf (mutant laking hpt) in HK- depleted host cells. The mutant 
(unable to use HP) showed wild type growth in HK- depleted HeLa cells. This 
is indirect evidence for the previous conclusion that glucose (before being 
phosphorylated) is a major carbon source for intracellular L. monocytogenes. 
In conclusion, the results from the proliferation in knock down cells in 
addition with the glucose- uptake mutant experiments indicate that glucose 
(before its conversion into G6P) is an essential carbon source for intracellular 
L. monocytogenes replication. Moreover, our results show that there is no 
difference in L. monocytogenes carbon metabolism between intra- and 
extracellular conditions, behaving similarly to other intracellular pathogens 
with an active cytosolic replication (Gotz et al, 2010). This is also concordant 
with analyses of the Listeria genome that show no substantial metabolic 
differences between environmental strains and pathogenic strains that have 
evolved an intracellular life -cycle (Wife-Lee and McClarty 2000). 
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4. Conclusions and future work 
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4.1 Conclusions 
The experimental work described in this project has led to the 
following conclusions: 
(i) We in vitro characterized AptsH confirming previous 
observations from other groups that determine PTS system as the main in 
vitro glucose transporter for L. monocytogenes. We have also studied AptsH 
intracellular replication demonstrating the role of the PTS system as the 
principal intracellular glucose up- taker. 
(ii) We built, characterized and studied the intracellular growth of 
two L. monocytogenes strains defective in the most important glucose 
transport systems for the bacteria: pAUL- A::g /cU1 defective in the low- affinity 
non -PTS up -taker GIcU1 and AptsH,pAUL- A::glcU1 defective in both PTS 
and non -PTS transporters. Our results support an important role of GIcU1 as 
a non -PTS glucose transporter in vitro, whose action is clearly reflected in the 
absence of the PTS system. We could appreciate some intracellular glucose 
up -take through GIcU1, however the contribution of this transporter in vivo is 
not as important as its function in vitro. 
(iii) Our work with AptsH, pAUL- A::g/cU1 and AptsH,pAUL- 
A::gIcU1 provides strong experimental support to the notion that L. 
monocytogenes uses mainly glucose as a carbon source in in vitro conditions 
and when parasiting a cell. 
(iv) We identified four HK in HeLa cells, HK1, HK2, HK3 and GCK 
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and we have demonstrated the efficiency of the selected siRNA depleting the 
action of theses intracellular proteins. 
(v) We confirm previous observations from our laboratory that 
suggested that L. monocytogenes deficient in the HP transport was able to 
use free intracellular glucose showing wild type growth. These results 
indirectly support the idea of glucose as a sufficient and essential carbon 
source for intracellular L. monocytogenes. 
4.2 Future work 
Future directions of the research based on the findings and work 
reported in this project are: 
(i) To investigate the effect of the complete deprivation of 
intercellular glucose and G6P for the bacteria in order to definitely determine 
which carbon sources are essential for the intracellular parasitic L. 
monocytogenes. For that purpose the construction, characterization and a 
intracellular behaviour study of double and triple mutants in the Hpt 
transporter and the PTS system, as well as combined with the non -PTS 
sugar transporter GIcU1 will be the next step to follow. 
(ii) Future work will also focus on the construction, 
characterization and intracellular growth study of single mutants for the other 
two non -PTS glucose transporters GlcU2 and GlcU3 and double mutants 
combining them with for the mutation in the PTS system, in order to 
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determine the function of GlcU2 and GIcU3 in L. monocytogenes intracellular 
glucose transport. It will be also a priority in our research, a further 
optimisation of the experimental conditions for the visualization of intracellular 
L. monocytogenes PTS- GIcU1-. 
(iii) It will also be interesting to investigate the behaviour of the 
mutant strains PTS- and PTS- GIcU1", already characterized and studied, in 
an in vivo mouse model, to see if the bacteria follows the same pattern in a in 
vivo infection. 
(iv) Seen the results achieved doing proliferations of L. 
monocytogenes wild type and Ahpt in HK- depleted HeLa cells, future work 
will also focus on adapting the siRNA knockdown assay to a mouse model in 
order to investigate how Hpf behaves in an in vivo proliferation. 
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5. Materials and Methods 
5 
5.1 Microbiological techniques 
5.1.1 Bacterial strains and culture conditions 
L. monocytogenes serovar 1/2a strain EGD -e (Glasser et al., 2001), 
serovar 4b strain P14 (Rippio et al., 1997) and E. coli DH5 (Hanahan, 1985) 
were used to carry out the experiments (Table 1). Listeria strains were 
routinely cultured in BHI (Difco Laboratories -Beckto). L. monocytogenes 
mutants deficient in the uptake of glucose were grown in LB (Sigma) 
supplemented with 20mM of uridine as a carbon source (Sigma). E. coli 
strains were routinely cultured in LB media. In order to prepare solid growth 
media, 1.6 % of bacteriological agar (Oxoid) was added to the broth media. 
Listeria was grown at 37 °C (shaking at 200 rpm for liquid cultures). Media 
was supplemented with erythromycin (Em) or chloramphenicol (Cm)(Sigma) 
when it was required. 
5.1.2 Listeria chemical defined media preparation 
IMM was prepared according to Phan -Than & Gormon (1997) with 
modifications (Table 2). IMM medium was stored at 4 °C for periods of no 
longer than two weeks and protected from light. Selected carbon source was 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































KH2PO4 6,56 g/L 
100 ml Na2HPO4* 7 H2O 30,96 g/L 
MgSO4 * 7 H2O 0,41 g/L 10 ml 
Ferric citrate 88 mg /L 8 ml 
L - Glutamine 0,6 g/L 10 ml 
L - Leucine 0,1 g/L 10 ml 
DL - Isoleucine 0,1 g/L 10 ml 
DL - Valinie 0,1 g/L 10 ml 
DL- Methionine 0,1 g/L 10 ml 
L - Arginine Hcl 0,1 g/L 10 ml 
L- Cysteine Hcl 0,1 g/L 1 ml 
L - Histidine Hcl 0,1 g/L 10 ml 
L - Tryptophan 0,1 g/L 10 ml 
L- Phenylalanine 0,1 g/L 10 ml 
Adenine 2,5 mg /L 0,5 ml 
Biotin 0,5 mg /L 1 ml 
Riboflavine 5 mg /L 20 ml 
Thiamine Hcl 1 mg /L 1 ml 
Pyridoxal HCL 1 mg /L 1 ml 
Para - aminobenzoic acid 1 mg /L 1 ml 
Calcium panthothenate 1 mg /L 1 ml 
Nicotinamide 1 mg /L 1 ml 
Thioctic acid (a- lipoic acid) 5 mg /L 100 pl 
H2O (deionised & autoclaved) 760 ml 
Table 2. IMM composition. 
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5.1.3 Listeria inocula preparation 
Bacteria pre -inocula was set up placing several well -isolated colonies 
from a pure culture into 10 ml of BHI broth for an overnight culture. The 
following day, bacteria from the overnight culture were inoculated 1:100 into 
200 ml of BHI broth for a new incubation until reaching an OD600 of 1. 
Bacteria culture was centrifuged at 7,000 x rpm for 10 min at 4 °C. Three 
washes in ice -cold PBS (Fluka- Sigma), were performed and the pellet from 
the last wash was re- suspended in 4 ml ice -cold 20% glycerol (Sigma) PBS. 
100p1 aliquots were dispensed into tubes and stored at -80 °C until use. In 
order to determine the number of bacteria present in the frozen inocula 
stocks, three aliquots were serial diluted and plated in BHI and then the 
average CFU /ml was calculated. 
5.1.4 Bacterial growth curve 
Bacterial population size in broth culture can be estimated by 
measuring its turbidity using a spectrophotometer. The day before the 
experiment, a pre -inoculum was prepared as it has been previously specified 
in Section 5.1.3. This step is important to guarantee that all the bacteria are 
at the same stage by the time of the experiment. The day of the experiment, 
the overnight culture was centrifuge at 7,000 x rpm for 10 min and the pellet 
was washed twice with PBS to be finally resuspended in 10 ml of PBS. 0D600 
was measured and an appropriate volume of the bacteria in PBS was mixed 
with 1m1 of selected media to reach an OD600 
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0.02. To set up the flat 
bottom 96 -well plate (Nunc Thermo Scientific), 200 µL of the bacteria in the 
appropriate media were added per well. Three technical replicates were 
made for each strain. Plates were at 37 °C shaking and measurements were 
taken every 30 min. A Fluorostar Omega plate Reader (BMG LABTECH) was 
used to measure the growth. Data were analyzed using MARS Data Analysis 
Software (BMG LABTECH). 
5.1.5 Competent cells preparation 
5.1.5.1 L. monocytogenes electrocompetent cells 
The day before competent cells preparation, a pre -inoculum was 
prepared as it has been described in Section 5.1.3. The culture was diluted 
1:100 in 0.5 M sucrose (Sigma) BHI and incubated under the same 
conditions until reaching an OD600 = 0.2. Then, 10 pg /ml penicillin G (Sigma) 
was added and the culture was incubated for further 2h under the same 
conditions. After that, bacteria were transferred to sterile ice -cold centrifuge 
tubes to spun them at 7,000 x rpm for 10 min at 4 °C. Ice -cold transformation 
buffer was prepared by mixing 0.5 M sucrose, 1 mM (4-(2- hydroxyethyl) -1- 
piperazineethanesulfonic acid (HEPES, Sigma) in Milli -Q water to wash the 
cells up to three times. The final pellet was re- suspended in 200 pl of ice -cold 
transformation buffer containing 10% glycerol. 50 pl aliquots were dispensed 
into sterile microfuge tubes previously chilled at -80 °C. Competent cells were 
immediately stored at -80 °C until use. 
5.1.5.2 E. coif chemical competent cells 
From an overnight pre -inoculum (preparation described in Section 
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5.1.3), an inoculum was set up diluting the overnight culture 1:100 in 100m1 
of LB broth media. Once inoculum reached an OD600 = 0.5, bacteria were 
passed to centrifuge tubes and incubated on ice for at least 10 min. After this 
time, tubes were centrifuged at 7,000 rpm during 10 min at 4 °C. The pellet 
was resuspended in 20 ml of Solution I and left again on ice for at least 
another 10 min. Bacteria were centrifuged under same conditions as before 
and the pellet was resuspended in 4ml Solution II. 150 pl aliquots were 
dispensed into sterile microfuge tubes and stored at -80 °C. 
Solution I: 10mM sodium acetate (AcNa, Sigma) pH= 5.6 -6, 50mM 
manganese (II) chloride (Cl2Mn, Sigma) and 5mM sodium chloride (CINa, 
Sigma). Solution II: 10mM AcNa pH= 5.6 -6, 5% glicerol, 70mM calcium 
chloride (Cl2Ca, Sigma) and 5mM Cl2Mn. 
5.2 Molecular biology techniques 
5.2.1 DNA techniques and sequence analysis 
5.2.1.1 Polymerase chain reaction 
The oligonucleotides used in this project (Table 3) were designed 
using L. monocytogenes EGDe genome as a reference (Glasser et al., 2001) 
and purchased from Sigma Genosys. Genomic DNA was extracted from the 
bacteria using GenElute Bacterial Genomic DNA Kit (Sigma) following 
manufacturers instructions. Polymerase chain reactions (PCRs) were carried 
out using C100 thermal cycler (Bio -Rad). 
Taq DNA polymerase (Biotools) was used for routine checking, following 
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general parameters: 5 min at 95 °C of initial denaturation; 30 cycles of 
amplification involving 30s at 95 °C of denaturation, 30s of oligonucleotide 
hybridization at the appropriate melting temperature and 2 min elongation at 
72 °C plus another 10 min also at 72 °C of final elongation after the last cycle. 
A master mix volume of 25 pl per reaction was used for Taq polymerase 
PCRs mixing 100 ng of DNA template, 0.5 pl of 10 mM dNTPs (Biotools), 1 pl 
of each 10 pM oligonucleotides, 2.5 pl of Taq polymerase buffer and 1 pl 10x 
Taq polymerase. 
PfuUltra 11 fusion HS DNA polymerase (Stratagene) was used when 
high -fidelity PCR was required. Thermal cycler parameters were set as 
follows: initial denaturation for 2 min at 95 °C; 30 cycles of amplification 
involving denaturation for 20s at 95 °C, oligonucleotide hybridisation for 20s at 
the appropriate temperature (Table 3) and elongation at 72 °C 30s; and final 
elongation for 5 min at 72 °C. 50 pl master mix was used according to the 
manufacturers conditions: 100 ng of DNA template, 0.25 pl of 10 mM dNTPs 
(Biotools), 0.5 of each 10 pM oligonucleotides, 5 pl of Taq polymerase buffer 
and 0.5 pl PfuUltra II polymerase. 
PCR products were visualized on 1% agarose gels (Biotools) by 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.2.1.2 Sequence analysis 
For cloning purposes, PCR products were purified from the agarose 
gel with QlAquick Gel Extraction Kit (Qiagen) following manufacturer 
conditions. Nanodrop(R) Spectrophotometer (ThermoScientific) was used to 
assess DNA purity and concentration. DNA samples with an A260/A280 
absorbance ratio lower than 1.75 - 1.80 were discarded. 
DNA samples were submitted to GenePool (University of Edinburgh) 
for Sanger sequencing. Sequences and chromatograms were analyzed using 
ApE plasmid Editor (Wayne Davis). The Alignment of DNA sequences was 
performed by using Basic Local Alignment Search Tool (Blast, 
http: // blast .ncbi.nlm.nih.gov /Blast.cgi). 
5.2.1.3 Digestion and ligation 
PCR and plasmid digestions were carried out using restriction 
enzymes. All enzymes were obtained from Promega (Biolabs) and they were 
used according to the manufacturer's instructions: 1 pg of purified PCR 
product/ plasmid was double digested within 50 pl reaction using 1 pl of each 
restriction enzyme, 511I of 10 x bovine serum albumin (BSA) and 5 of 
appropriate reaction buffer. The digestion was incubated at 37 °C during 2 -24 
h (depending on the enzyme) and subsequently PCR fragments were ligated 
with the plasmid using T4 ligase (Promega Biolabs) according to 
manufacturer's instructions: 100ng of DNA vector, 17ng of DNA insert, 1p of 
Ligase 10 x buffer T4 DNA, 1 pl ligase and nuclease -free water to final 
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volume of 10pI were assembled in a sterile microcentrifuge tube. The 
reaction was incubated at 16 °C overnight and then incorporated by 
transformation into the appropriate bacterial strain. 
5.12 Plasmid extraction and transformation 
E. coli DH5a was used to clone and maintain plasmids. Vectors were 
introduced by heat shock: 10µI of the insert- vector complex were mixed with 
75p1 chemically competent E. coli (see section 5.1.5.2) and placed on ice for 
30 min. After that time, mix was passed to a heat block at 42 °C for 2 min, to 
come back to ice for farther 5 min. 900111 of BHI were added to the 
transformation mix to be then incubated for one hour at 37 °C and 
subsequently plated in LB 250pg /ml erythromycin (LB Em 250) or LB 15 
pg /mI chloramphenicol (LB Cm 15) plates as required. Plasmids were 
extracted from E. coli using QlAprep(®) Spin Miniprep Kit (Qiagen), 
according to manufacturer's instructions. 
Plasmids were introduced inside L. monocytogenes by 
electroporation. Listeria electro- competent (see section 5.1.5.1) were 
defrosted on ice and mixed with 10 ng /pl of plasmid. The mix was transferred 
into an ice -cold 2 mm electroporation cuvette (Bio -Rad) and kept on ice for 5 
min. Then the cuvette was placed in a GenePulserXcell electroporator 
(Biorad) with the following settings for electroporation: voltage = 2900 V, 
capacitance = 25 pF, resistance = 100 S2. After transformation, 900 pl of BHI 
broth was added to the bacterial cells and the cuvette content was 
transferred into microfuge tube. Bacteria in BHI were incubated at 37 °C for 
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1h and plated onto BHI agar plates containing the appropriate antibiotic 
(514/ml erythromycin or 7.5 pg /ml chloramphenicol). Transformants 
appeared within 24 - 48 h of incubation at 37 °C. 
5.2.3 Construction of insertion mutants in Listeria 
L. monocytogenes EGDe insertion mutants were constructed using a 
modification of the homologous recombination technique previously 
described by Dominguez -Bernal et al. 2006. 
Gene glcU1 was amplified with 0184_INF and 0184_INR primers 
(Table 3) and cloned into pAUL -A plasmid (Chakraborty et al., 1992) to 
generate pAUL- Ag /cU1 that was introduced into E. coli . Transformants were 
restricted in LB Em 250 and checked by PCR (using PaulaF and PaulaR 
primers, figure 21). plasmid was extracted and electroporated in EGD -e. One 
colony carrying the construction was inoculated in 10 ml LB broth with 5 
pg /ml , 20 tag /ml uridine (as an extra carbon source due to the incompetence 
of these strains to use glucose) and incubated at 30 °C overnight. The 
overnight culture was diluted in PBS 1:100 and 100 pl of the dilutions (10 
"3 
to 
10 -6) were plated out onto pre- warmed 42 °C BHI Em5 agar plates. Colonies 
that appeared after 48h incubating at 42 °C were checked by PCR to select 
the strains EGD,g /cU1::pAUL -A and EGDAptsH,g1cU1::pAUL -A (Table 3). 
5.2.4 Mutant complementation by site -directed mutagenesis 
Complementation plasmid pPL2- P6ptsH was constructed to restore 
the function of the Hpr protein from the PTS system. ptsH gene was 
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amplified by PCR with ptsHC_F1_BamHI and ptsHC_R1_Spel primers 
(Table 3). PCR product was purified and cloned into the high -copy plasmid 
pCR Blunt vector (Invitrogen) in order to increase the insert concentration. 
After transforming into E. coli, the plasmid was extracted and digested with 
Spel and BamHI to release the insert. Once purified, the digested insert was 
transferred to pPL2 -P8 vector. This plasmid was then introduced into L. 
monocytogenes EGD -e AptsH by electroporation and the resulting colonies 
were checked by PCR. 
pPL2 -P6 (Figure 22) is a modification of the original pPL2 plasmid 
(Lauer et al., 2002) produced in our laboratory (de las Heras, unpublished 
data): the strong constitutive promotor Pb was added to the site -specific 
phage integration vector pPL2 generating an integrative vector with a strong 
promotor to express a selected inserted gene. Thus, the expression of ptsH 
was driven by the PS promotor. 
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0184_INF 0184_INR 















Figure 21. Schematic representation of the recombinogenic plasmid construction for 
an insertion mutant. The grey arrow represents the chromosomal gene to interrupt. Primers 
0184_INF and 0184_INR (each of them with one restriction site at the 5' end) are 
represented with two small black arrows. Primers amplified a region of 632 bp in the middle 
of the gene (grey square represents), which was subsequently digested Barn HI /Hind Ill 
(small vertical pointed arrows) and inserted into pAUL -A, giving the recombinogenic plasmid. 
The presence of the insert inside the plasmid was checked by PCR using primers Paula F 
and Paula R. 
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6421 Drall (1) 
6233 ApaLl (1) 
5897 Mfel (1) 
Cm gram + 5928..5278 
5343 BsaB1 (1) 
5296 Stul (1) 
5116 Sfol (1) 
5116 Nari (1) 
5116 Kasl (1) 
5116 Bbel (1) 
5101 Bgll (1)I 
5095 Fspl (1)\ 
LacZ alpha 5049..5117\ 
5075 Pvul (1) 
M13 -fwd 4978..4961 
T3 7..26 
36 Kpnl (1) 
c C. Acc651 (1) 
Pdelta 42..140 
141 BamHI (1) 
Bam Hl forward primer 147..170 
420 Xcml (1) 
Spei Reverse Primer 453..469 
470 Spel (1) 
482 Notl (1) 
483 Eagl (1) 
489 BstXl (1) 
4900111(1) 
500 Sacl (1) 
567 Tth1111 (1) 
PPL2 1R 701..681 
700 Scal (1) 
pPL2-Pdelta 
4512Bglll(1) 
3712 Swal (1) 
3621 Mlul (1) 
3620 Eam11051 (1) 
6478 bp 
2981 Sphl (1) 
Jlll9AcciiI 
1115 EcoRI (1) 
(1) 
1451 PíIMI (1) 
1708 BstZ171 (1) 
Figure 22. Schematic representation of pPL2 -P3 vector (de las Heras, unpublished 
data) 
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5.3 Cell -based techniques 
5.3.1 Mammalian cell culture 
The human epithelial cell line HeLa (CCL -2) from ATCC repository 
was used to accomplish our experiments. Cell monolayers were grown in 
Dulbeco's modified Eagle's medium (DMEM, Gibco BRL) containing 10% 
heat -inactivated foetal serum bovine (FBS, Gibco BRL) and 10 mM glucose. 
Cells were incubated at 37 °C in a 5% 002 atmosphere. 
5.3.2 siRNA transfection in HeLa cells 
LipofectamineTM 2000 (Thermo Fisher, UK) has been used to 
contrafect siRNA (Dharmacon, Thermo Fisher) (Table 4) molecule into HeLa 
cells. One day before transfection, HeLa cells were seeded in DMEM 10mM 
glucose medium. The cell density per well and all the volumes of the different 
reagents were adjusted depending on the culture vessel (Table 5). Both 
siRNA and lipofectamine were separately diluted in Optimem media (Gibco 
BRL). Then siRNA is added to lipofectamine and the mixture was incubated 
for 30 min at room temperature allowing the formation of siRNA- 
lipofectamine complexex. Before adding the complexes to the cells, DMEM 
media was changed from 10mM to 25mM glucose. Then complexes were 
added to the cells, drizzling the drops across the whole surface and mixing 
gently by rocking the plate back and forth. Cells were incubated at 37 °C, 5% 
CO2 and after 4h growth, DMEM 25mM glucose was replaced with DMEM 
5mM glucose and incubated at same conditions for 24h. 
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NEXOKINASE SEQUENCE NUMBER BRAND 
HKi 
0- 006820 -01 
D- 006820 -03 





Therm0-Sc entif c 
0- 006735 -02 Thermo- Scientific 
D- 006735 -03 
D- 006735 -04 
Thermo -Scientific 
Thermo -Scientific 
D- 006735 -05 Thermo -Scientific 
D-006736-01 Thermo-Scientific 
HO D- 006736 -02 
D- 006736 -03 
Thermo- Scientific 
Thermo-Scientific 
D- 006736 -04 Thermo- So entific 
D- 010819 -01 Thermo -Scientific 
GCK (HK4} 
D- 010819 -02 
0- 010819 -03 
Thermo- Sclentlfic 
Thermo- Scientific 
D- 010819 -04 Thermo- Scientific 



























































































































































































5.3.3 Preparation of HeLa cell extracts 
Extracts from transfected HeLa cells (see section 5.3.3) were prepared 
4h after transfection. Cells from 3 wells from a six -well plate made one 
extract. Media was removed from the cell plate, cells were washed twice with 
Dulbeco modified PBS (D -PBS) and placed on ice. Cell monolayers were 
scrapped in the presence of 80 pl /well of lysis buffer containing 50mM Tris 
hydrochloric (HCI, Sigma) ph7.4; 150 mM sodium choride (NaCI, Sigma); 
1mM EDTA(Sigma); 1% tTriton -X -100 (Sigma); 0.5 sodium fluoride (NaF, 
sigma); 1mM sodium orthovanadate (Na3VO4, Sigma); 1 tablet of protein 
inhibitor cocktail EDTA free (Roche); 1mM tosyllysine chloromethyl ketone 
hydrochloride (TLCK, Roche); 1mM dithiothreitol (DTT, Roche). Extracts were 
collected in a microtube and placed on ice for 30 min vortexing from time to 
time. Then, extracts were centrifuge at 4°C, 10,000 rpm during 10 min. 
Supernatant was collected and frozen at -80 until analysis. 
5.3.4 Intracellular proliferation assays 
HeLa cells were cultured in a 24 -well plate (Costar®- Corning) at a 
concentration of 3.5 x 104 cells /well, incubated at 37 °C under 5% CO2 in 
DMEM 10% FBS. Bacteria were added to cells using the appropriate MOI 
and the infected monolayers were centrifuged at 900 rpm for 3 min at room 
temperature to synchronize the infection. After centrifugation, infected cells 
were incubated for 20 min at 37 °C in 5% CO2 atmosphere. Cell monolayers 
were washed twice with D -PBS (Sigma) to remove non -adherent bacteria, 
and incubated during 1h in DMEM containing 25 pg /ml gentamicin (Sigma) to 
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kill live extracellular bacteria. Infection time 0 was determined 1h after the 
addition of gentamicin. At specific time points, two wells per strain were 
washed twice with D -PBS and cells were lysed by adding 100 pL 1% Triton 
X -100 (Sigma) for 3 min, and subsequently 400 pL of D -PBS. Appropriate 
dilutions were then performed for bacterial counting on BHI agar. IGC was 
used to normalised the intracellular bacterial growth data for the bacterial 
population at t = 0. 
IGC 
(IB t=n- IB t=o) 
IB t= 
IB f=n numbers of intracellular bacteria at time points t = n 
IB t= o numbers of intracellular bacteria at time points t = 0 
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5.4 Biochemistry 
5.4.1 Sugar -phosphates fermentation assay 
The capacity of the bacteria to utilize HPs was measure in phenol red 
broth supplemented with glucose -1- phosphate (G1 P) or G6P (Sigma) at a 
final concentration of 10mM. A stock of 100 ml phenol red broth was prepared 
by mixing 1.5 g of phenol red broth in 100m1 of distilled water. To prepare the 
phenol red charcoal, 0.2 g of activated charcoal (Merk) were added 100m1 of 
the phenol red broth. A single colony was cultured in 1 ml G1 /6P- 
supplemented phenol red broth at 37 °C during at least 24 h. Results reading 
was performed at 24h and 48h. 
5.4.2 Measurement of lecithinase activity 
The activity of the PrfA- dependent PIcB gene was semi -quantified in BHI 
agar plates supplemtned with lecithin solution with or without activated 
charcoal. The lecithin solution was prepared by mixing one egg yolk with 100 
ml of filter sterilized 0.9% saline solution. 10m1 of the lecithin solution were 
mixed with 100 ml of autoclaved BHI agar (prepared by mmixing 3.7 g of BHI 
(BD, BactoTM) and 1.6 g of Agar (OXOID) in 100 ml of distilled water). 13ml of 
media were pour per Petri dish. Lecithin charcoal plates were prepared on 
the same way with the addition of 0.5 g of charcoal to the BHI agar before 
autoclaving (BD, BBLTM). Single colonies were streaked onto the plates and 
incubated at 37° C during 24 - 48 h. Lecithin activity was measured by the 
presence of a turbid halo around the positive colonies. 
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5.4.3 SDS -PAGE electrophoresis 
Supernatant from cell extracts was mixed with 4x loading buffer 
(Sigma) and loaded in a NuPage precast gel (Life Technologies - Invitrogen). 
Samples were run in lx MOPS SDS -PAGE running buffer (3- (N- morpholino) 
propanesulfonic acid for Sodium dodecyl sulfate polyacrylamide) gel 
electrophoresis (Novex- Life Technologies) in a Novex mini cell tank 
(Invitrogen, UK) and Power Pac 300 (Bio -Rad). Once samples were loaded, 
gel was initially run at constant amperage of 40 mV until the samples start to 
move into the gel properly. When samples got around 10 mm inside the gel, 
amperage was increased to 80mV until the gel front reached the bottom of 
the gel. Proteins were then transferred from the gel onto a polyvinylidene 
difluoride membrane (PVDF, GE Health Care) by electrophoresis. 
5.4.4 Western blotting 
A western blotting cassette (Bio -Rad) was placed into a shallow tray 
part filled with 1 x transfer buffer containing: 10% 10x buffer stock, 20% 
methanol (Sigma,) and 70% distilled water. 10x stock buffer was prepared by 
mixing 144g of glycine (Sigma), 0.4% sodium dodecyl sulfate (SDS, 
Invitrogen) and 36g of TRIS base (tris (hydroxymethyl)aminomethane, 
Sigma). All membranes and filters were kept wet during the blotting stack 
construction to avoid the dehydration of gel and membrane that could disturb 
the transference. In order to build the blotting stack, a fibber pad support was 
placed at the bottom of the cassette. Then, two layers of Whatman paper 
(Whatman) cut to size were -placed at the top of the pad followed by a 
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NuPage gel, the Polyvinylidene fluoride (PVDF) membrane (previously 
activated wetting it in methanol) and another two layers of Whatman paper. A 
circular length of pipette was rolled across the top of the Whatman paper in 
order to squeeze out any bubbles between the layers that could disrupt the 
transfer. Transfer buffer was added over the stack for each additional layer. 
Another fibre pad was added to the top of the stack and then the cassette 
was closed and fitted into the blotting tank set up according to manufacturers 
directions. The blot was transferred at a constant voltage of 30mV overnight. 
Then the membrane was removed from the cassette ready for the antibody 
detection. 
5.4.5 Antibody detection 
The membrane was blocked with 5% of skimmed milk diluted in Tris- 
Buffered Saline with Tween 20 (TBST, Sigma) during 1 h at room temperature 
in a rolling shaker. Once the block was removed, the first antibody (Table 6) 
appropriately diluted in 5% skimmed milk TBST, was added. The membrane 
was incubated with the primary antibody for 1h under the same conditions 
mentioned above. After that, the membrane was washed three times with 
TBST buffer, with a period of 15 min per wash. Once the membrane is clean 
of primary antibody rests, appropriately diluted HRP- secondary antibody 
(Table 6) was added to be incubating for 1h. Finally, the membrane was 
again washed three times with TBST buffer and developed using ECL Plus 
Western Blotting Detection kit (GE Healthcare, Life Science) following 
manufacturers instructions. 
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Name Host Species Storage T Company Concentration 
Hexokinase 1 Rabbit -20C 
Cell 1:1000 Signalling 
Hexokinase II Rabbit -20C Cell 1:1000 Signalling 
Anti-HK-3 C 
Rabbit -20C Sigma 1:1000 Terminal 
Monoclonal Anti- 
Mouse -20C Sigma 1:2500 
GCK 
HRP Anti -Rabbit IgG Donkey 4C Amersham 1:5000 
Table 6. Table containing the antibodies used in this project 
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5.4.6 Determination of intracellular concentration of glucose and 
glucose phosphate 
HeLa cells from three 60mm Petri dishes made one extract. Cell 
monolayers were scrapped in presence of 100 µL of PBS 10% perchloric acid 
(Sigma) per extract and then centrifuged at 10,000 rpm at 4 °C for 15 min. 
The supernatant was collected to measure glucose and G6P after 
neutralizing the pH by adding 5 M potassium carbonate (K2CO3, Sigma) 
(Lang and Michal, 1974). The pellet was used to determine the total amount 
of protein in the extract using a quantification kit (Thermo Scientific) based on 
the pyrogallol red protein determination method (Anderson et al., 1981). 
Basically, the pellet was resuspended in 150 µL of 30% potassium hydroxide 
(KOH, Sigma) and the mixture was boiled at 100 °C for 15 min. 15 µL of the 
protein dilution were mixed with 200 µL of the Microprotein reagent (Thermo 
Scientific) and the absorbance was measured at 600nm. 
The total amount of glucose of each extract was determined by using 
a commercial kit (Thermo Scientific) based on the HK/G6P dehydrogenase 
(G6PDH) method (The American Association of Clinical Chemistry). HK 
catalyses the phophorylation of glucose by ATP producing G6P. G6P is at the 
same time oxidized to 6- phosphogluconate with the reduction of NAD+ to 
NADH by G6PDH. The amount of NADH formed is proportional to the 
concentration of glucose and can be measured by the increase in the 
absorbance at OD340. G6P was determined by a spectrophotometric assay 
using G6PDH, which oxidises the sugar phosphate into 6- 
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phosphogluconolactone. This compound converts spontaneously into 6- 
phosphogluconate generating NADH that is proportional to the G6P and can 
be quantified as described previously in this section. 





GlcSb - G6PSb 
Cello, 
Cella = mg protein 0.64 mL cell volume 
cell extract 
120mg 
Glcsb : ,u m glucose in cell extract supernatant 
G6Psb : ji m glucose in cell extract supernatant 
Cello,: extracts cell volume 
5.5 Microscopy techniques 
5.5.1 Actin staining 
The protocol to develop this assay was detailed in Deshayes et al. 
(2012), briefly: 5 x 104 HeLa cells /well were seeded in a 24 well -plates with a 
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coverslip in each well. Next day, cells were infected at a suitable MOI and 
sampled 4h after infection. Then, infected monolayers were washed three 
times in warm D -PBS to remove extracellular bacteria and 100 mg /ml 
gentamicin (Invitrogen) was added after 1h of infection to prevent 
extracellular bacterial growth. Coverslips were fixed with 3.7% (w /v) 
paraformaldehyde (Invitrogen) and prepared for microscopic examination by 
permeabilization with 0.2% (v /v) Triton X -100 (Sigma) in PBS for 15 min. A 
further incubation of 1 h with 1:1,000 AlexaFluor 568- conjugated phalloidin 
(lnvitrogen) and 1:50,000 DAPI (lnvitrogen) was performed to visualize F- 
actin and bacterial DNA/cell nuclei, respectively. After three washes in PBS 
and one wash in distilled water, coverslips were mounted using ProLong Anti - 
fade reagent (lnvitrogen) and mounting medium (Invitrogen). Images were 
acquired using 63 x oil objective in a Leica DMI 6000B immunofluorescence 
microscope and images were analyzed using Leica Application suit advanced 
fluorescence software (LAS -AF, Leica Microsystems). 
Quantification of vacuolar and cytosolic Listeria was performed by 
counting the proportion of bacteria associated/ non -associated with F -actin 
per image field. 
5.6 Statictical analysis 
For the comparisons of sample means in intracellular proliferation assays a 
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Appendix 1: Chromosomal site of HeLa cell Hexokinases 
Hexokinase 1 
Location: 10q22 
Sequence: Chromosome: 10; NC_000010.10 (71029756..71161638) 
Chromosome 10 - NC_000010.10 
[ 70 939993 11. [ 71193169 







Sequence: Chromosome: 2; NC_000002.11 (75059782..75120481) 
Chromosome 2 - NC 000002.11 
[ 74881393 F [ 75426645 
SEMA4F RPS28P5 HK2O POL E4 TACR1 
MIR5000 
Hexokinase 3 
Location : 5q35.2 
Sequence : Chromosome: 5; NC_000005.9 (176307870..176326333, complement) 
Chromosome 5 - NC_000005.9 
[ 1760 57683 po [ 17649375E 




Location : 7p15.3 -p15.1 
Sequence : Chromosome: 7; NC_000007.13 (44183870..44229022, complement) 
[ 44154279 Fr 
Chromosome 7 - NC_000007.13 
[44365230 F 
PUL 02 Rig YKT6 
GCK CAMK2B 
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Appendix 2: Trendlines for the determination of the intracellular glucose and G6I 
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